Satyadivis is one of the leading manufacturers of API's & Intermediates
Satyadivis has established In-house R&D for robust capabilities.
R&D Facililities
Our Research & Development division works on developing innovative ideas, methodologies and chemistry to deliver cost effective and safe process for new products development.
R&D at SDPPL has constantly provided support to existing products throughout the product life to ensure end to end support our global customers.
R&D is established to meet and develop molecules with stringent global regulatory requirement.
Our R&D has supported widely to maintain good trackrecord of deliverables made to customer world wide.
SDPPL as part of expansion is further strenthening its R&D by installing dedicated facility, Skilled manforce and modern technologies.
Scale Up
Our R&D works on continuous process development and Scaleup activities at various stages of product development.
Our scale UP process from gram level to commercial scales studies enables ease of commercialisation with cost effective and environment friendly process.
Our R&D Team at every stage with depth analysis provides clarity to take appropriate decision.
SDPPL provides importance to update the knowledge of our R&D by providing access to various research related sites.
Product Under Pipeline
SDPPL with a vision of future growth has started studies on various API’s to be developed in the near future. These products are at different level of development stages.
Dapoxetine HCl
Dorzolamide
Escitalopram Oxalate
Flupentixol Di HCl
Moxifloxacin Hydrochloride
Nebivolol
Pirfenidone
Tapentadol
Tizanidine HCL
SDPPL believes in strengthening R&D to develop product with environment friendly, Cost effective and smooth scaleble process.
